Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
This study evaluates the host genetic factors that influence serological response against EBV and history of IM and cross-evaluates them with MS risk and genetic susceptibility in the Swedish population. Plasma IgG antibody levels against EBV nuclear antigen-1 (EBNA-1, truncated=aa[325-641], peptide=aa[385-420]) and viral capsid antigen p18 (VCAp18) were measured using bead-based multiplex serology for 8744 MS cases and 7229 population-matched controls. The MS risk association for high/low EBV antibody levels and history of IM was compared to relevant clinical measures along with sex, age at sampling, and associated HLA allele variants. Genome-wide and HLA allele association analyses were also performed to identify genetic risk factors for EBV antibody response and IM history. Higher antibody levels against VCAp18 (OR=1.74, 95% CI=1.60-1.88) and EBNA-1, particularly the peptide (OR=3.13, 95% CI=2.93-3.35), were associated with an increased risk for MS. The risk increased with higher anti-EBNA-1 IgG levels up to twelve times the reference risk. We also identified several independent HLA haplotypes associated with EBV serology overlapping with known MS risk alleles (e.g., DRB1*15:01). Although there were several candidates, no variants outside the HLA region reached genome-wide significance. Cumulative HLA risk for anti-EBNA-1 IgG levels, particularly the peptide fragment, was strongly associated with MS. In contrast, the genetic risk for high anti-VCAp18 IgG levels was not as ...
Source: Cancer Control - Category: Cancer & Oncology Authors: Jesse Huang Katarina Tengvall Izaura Bomfim Lima Anna Karin Hedstr öm Julia Butt Nicole Brenner Alexandra Gyllenberg Pernilla Stridh Mohsen Khademi Ingemar Ernberg Faiez Al Nimer Ali Manouchehrinia Jan Hillert Lars Alfredsson Oluf Andersen Peter Sundstr Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Genetics | Glandular Fever (infectious mononucleosis) | Multiple Sclerosis | Neurology | Study | Sweden Health